Our R&D programmes focus on the development of prognostic and predictive glycomic blood biomarkers and Immunofrailty Model. These innovations will enable early detection and treatment personalisation for Inflammatory conditions in clinical practice.
How Immunofrail are you?
Glycan-based test that measures the fitness of your immune system from a small amount of blood.